论文部分内容阅读
目的观察缩宫素联合米索前列醇治疗产后出血的临床疗效。方法将78例剖宫产产妇随机分为观察组和对照组各39例。观察组产妇应用缩宫素联合米索前列醇进行治疗,对照组产妇单纯使用缩宫素进行治疗,比较2组治疗效果。结果观察组产妇产后总出血量为(317.2±27.9)ml,明显低于对照组(573.4±38.5)ml,差异有统计学意义(P<0.05);观察组产妇产后出血及不良反应发生率均低于对照组,差异均有统计学意义(P<0.05)。结论缩宫素联合米索前列醇治疗剖宫产产后出血临床效果显著,可有效减少产后出血及不良反应发生率,对保证孕产妇顺利分娩及新生儿安全具有重要推动作用。
Objective To observe the clinical efficacy of oxytocin combined with misoprostol in the treatment of postpartum hemorrhage. Methods 78 cases of cesarean section were randomly divided into observation group and control group 39 cases. The observation group maternal application of oxytocin combined with misoprostol for treatment, the control group of women simply treated with oxytocin, the treatment effect of two groups were compared. Results The total amount of postpartum hemorrhage in the observation group was (317.2 ± 27.9) ml, which was significantly lower than that in the control group (573.4 ± 38.5) ml, the difference was statistically significant (P <0.05). The incidence of postpartum hemorrhage and adverse reactions in the observation group were Lower than the control group, the difference was statistically significant (P <0.05). Conclusion Oxytocin combined with misoprostol for cesarean section postpartum hemorrhage clinical results were significant, can effectively reduce the incidence of postpartum hemorrhage and adverse reactions, to ensure the smooth delivery of pregnant women and neonatal safety has an important role in promoting.